MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

buy on rumour play 92c, page-7

  1. 643 Posts.
    jevalent, i tend to disagree, the lower cost of manufacturing a lower dosage drug is actually of huge benefit to the end price profit margin, being involved in drug trials of other sorts, the lower the dosage the higher the profit margin
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.